Organization
Beijing Anzhen Hospital
8 clinical trials
Clinical trial
Efficacy of DApagliflozin on REcurrence After Catheter Ablation for Atrial FibrillationStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Randomized Active-Controlled Study Comparing Efficacy and Safety of Nifekalant to Amiodarone in New-Onset Atrial Fibrillation After Cardiac SurgeryStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Cardiovascular Risk Reduction in Atrial Fibrillation TrialStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine (TACTIC): a Randomised, Double-blinded, Placebo-controlled, Multicentric TrialStatus: Not yet recruiting, Estimated PCD: 2026-05-01
Clinical trial
Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease With a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies Based on Multi-center Collaboration in ChinaStatus: Not yet recruiting, Estimated PCD: 2023-09-01
Clinical trial
CYP2C19 Genotype-GUided Dual Antiplatelet theRapy in pAtieNts Treated With New Generation Drug Eluting stEnts (the GUARANTEE Study)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Impact of Early CRRT Intervention in Patients Receiving VA-ECMO Support on 30-day Mortality: A Randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-10-22
Clinical trial
Randomized Comparison of Anticoagulation After Primary Percutaneous Coronary Intervention Using Enoxaparin, ACT Guided Unfractionated Heparin or Bivalirudin Prolongation vs. no Anticoagulation To Improve Clinical OutcomeStatus: Completed, Estimated PCD: 2022-11-23